| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/01/2023 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 4.7k | $0.77 | $3.6k | | 01/01/2023 |
| 01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 7.1k | $5.34 | $38k | | 01/31/2022 |
| 01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Common Stock | 1.9k | $0.00 | $0 | | 01/31/2022 |
| 01/01/2022 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 20k | $2.39 | $47.8k | | 01/01/2022 |
| 03/04/2021 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 7.5k | $8.00 | $60k | | 03/04/2021 |
| 03/12/2020 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 6.5k | $1.89 | $12.3k | | 03/12/2020 |
| 03/14/2019 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 25k | $1.38 | $34.5k | | 03/14/2019 |
| 01/31/2019 | Zyla Life Sciences | ZCOR | Disposition | Stock Option (right to buy) | 110k | $0.40 | $44k | | 01/31/2019 |
| 07/02/2018 | Zyla Life Sciences | ZCOR | Grant | Stock Option (right to buy) | 110k | $0.40 | $44k | | 07/02/2018 |
| 06/12/2018 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 5.5k | $5.23 | $28.8k | | 06/12/2018 |
| 03/13/2018 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 11k | $5.24 | $57.6k | | 03/13/2018 |
| 12/20/2017 | Aravive, Inc. | ARAV | Grant | Common Stock | 11.2k | $0.00 | $0 | | 12/20/2017 |
| 05/25/2017 | Aravive, Inc. | ARAV | Grant | Common Stock | 3.5k | $0.00 | $0 | | 05/25/2017 |
| 05/25/2017 | Aravive, Inc. | ARAV | Grant | Stock Option (Right to Buy) | 6.8k | $15.83 | $108.4k | | 05/25/2017 |
| 05/16/2017 | XOMA Corp | XOMA | Sale | Common Shares | 39.5k | $6.24 | $246.9k | | 05/16/2017 |
| 05/18/2016 | Aravive, Inc. | ARAV | Grant | Common Stock | 4.6k | $0.00 | $0 | | 05/18/2016 |
| 05/18/2016 | Aravive, Inc. | ARAV | Grant | Stock Option (Right to Buy) | 14.6k | $8.12 | $118.8k | | 05/18/2016 |
| 11/14/2012 | XOMA Corp | XOMA | Sale | Common Shares | 1.8k | $2.56 | $4.6k | | 11/13/2012 |
| 11/14/2012 | XOMA Corp | XOMA | Sale | Common Shares | 38.8k | $2.56 | $99.2k | | 11/13/2012 |
| 11/13/2012 | XOMA Corp | XOMA | Exercise | Restricted Stock Units | 4.5k | $0.00 | $0 | | 11/13/2012 |
| 11/13/2012 | XOMA Corp | XOMA | Exercise | Restricted Stock Units | 96.2k | $0.00 | $0 | | 11/13/2012 |
| 05/26/2011 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 5k | $3.03 | $15.2k | | 05/26/2011 |
| 01/07/2011 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 7.8k | $5.83 | $45.5k | | 01/07/2011 |
| 07/21/2010 | XOMA Corp | XOMA | Grant | Non-Qualified Share Option (right to buy) | 75k | $0.35 | $26.2k | | 07/21/2010 |